InVivoMAb anti-human CSF1R (CD115)

Hoffmann S, Murrell J, Harms L, et al. Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Brain Pathol. 2014,24(5):452-8. doi: 10.1111/bpa.12120

Chihara T, Suzu S, Hassan R, et al. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 2010,17(12):1917-27. doi: 10.1038/cdd.2010.60

Fuhrman B, Partoush A, Volkova N, et al. Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulating factor receptor (M-CSF-R). Atherosclerosis. 2008,196(2):598-607.

Kirma N, Hammes LS, Liu YG, et al. Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression. Cancer Res. 2007,67(5):1918-26.

Tan BL, Hong L, Munugalavadla V, et al. Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor. J Biol Chem. 2003,278(13):11686-95.

Rosenfeld CS. Transforming growth factor-beta 1 augments macrophage-colony stimulating factor activity on human marrow. Stem Cells. 1994,12(5):527-32.